R1 RCM Inc  

(Public, NASDAQ:RCM)   Watch this stock  
Find more results for tse:rcm
-0.09 (-1.71%)
After Hours: 5.17 0.00 (0.00%)
Feb 22, 4:00PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.16 - 5.34
52 week 2.02 - 5.43
Open 5.25
Vol / Avg. 164,093.00/217,407.00
Mkt cap 549.75M
P/E     -
Div/yield     -
EPS -0.28
Shares 104.52M
Beta -0.41
Inst. own 50%
Jan 10, 2018
R1 RCM Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -2.92% 29.88%
Operating margin -4.14% 50.27%
EBITD margin - 52.79%
Return on average assets -4.15% 40.46%
Return on average equity -41.24% -
Employees 6,113 -
CDP Score - -


401 N Michigan Ave Ste 2700
CHICAGO, IL 60611-4217
United States - Map
+1-312-3247820 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


R1 RCM Inc. is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship. The Company's PAS offering assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes. The Company also provides customers with retrospective appeal management service support for both governmental and commercial payers. Its physicians conduct detailed retrospective reviews of medical records to identify medical necessity for hospital services and the required documentation to support an appeal.

Officers and directors

Steven J. Shulman Chairman of the Board , Independent Director
Age: 65
Bio & Compensation  - Reuters
Joseph Gerard Flanagan President, Chief Executive Officer, Director
Age: 45
Bio & Compensation  - Reuters
Christopher Simon Ricaurte Chief Financial Officer, Treasurer
Age: 57
Bio & Compensation  - Reuters
Thomas A. Lesica Chief Operating Officer, Executive Vice President
Age: 57
Bio & Compensation  - Reuters
Gary Steven Long Executive Vice President, Chief Commercial Officer
Bio & Compensation  - Reuters
Michael C. Feiner Director
Age: 74
Bio & Compensation  - Reuters
John Bell Henneman III Director
Age: 55
Bio & Compensation  - Reuters
Joseph R. Impicciche Director
Age: 59
Bio & Compensation  - Reuters
Neal Moszkowski Director
Age: 51
Bio & Compensation  - Reuters
Ian R. Sacks Director
Age: 46
Bio & Compensation  - Reuters